Related Experiment Video

Updated: Jun 25, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Activation of apoptotic protein in U937 cells by a component of turmeric oil

Yongkyu Lee1

  • 1Department of Food and Biotechnology, Dongseo University, Busan 617-716, Korea. lyk@dongseo.ac.kr

BMB Reports
|March 3, 2009
PubMed

Insights

Aromatic turmerone from turmeric oil induces apoptosis in human lymphoma cells by activating caspase-3. This natural compound effectively inhibits cancer cell proliferation and triggers programmed cell death via specific protein pathways.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Aromatic (ar)-turmerone, a compound found in turmeric oil, exhibits anti-tumorigenesis properties, including the inhibition of cancer cell proliferation.
  • Understanding the molecular mechanisms behind its anti-cancer effects is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the role of ar-turmerone in activating apoptotic proteins in human lymphoma U937 cells.
  • To elucidate the specific molecular pathways involved in ar-turmerone-induced apoptosis.

Main Methods:

  • Treatment of human lymphoma U937 cells with varying concentrations of ar-turmerone.
  • Assessment of cell viability using assays.
  • Analysis of DNA fragmentation and sub-diploid cell populations.
  • Western blot analysis to detect the expression of apoptosis-related proteins (Bax, p53, Bcl-2, p21).
  • Measurement of mitochondrial cytochrome c release and caspase-3 activation.

Main Results:

  • Ar-turmerone significantly inhibited U937 cell viability in a dose-dependent manner (over 84% inhibition).
  • The treatment induced characteristic hallmarks of apoptosis, including nucleosomal DNA fragmentation and an increase in sub-diploid cells.
  • Apoptosis was associated with increased expression of Bax and p53, but not Bcl-2 or p21.
  • Mitochondrial cytochrome c release and caspase-3 activation were observed, indicating caspase-dependent cell death.

Conclusions:

  • Ar-turmerone induces apoptosis in human lymphoma U937 cells through a mechanism involving caspase-3 activation.
  • The apoptotic effect appears to be mediated by the induction of Bax and p53 proteins.
  • These findings highlight the potential of ar-turmerone as a therapeutic agent against lymphoma.

More Related Videos

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c07:42

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c

Published on: June 29, 2011

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.